Gastroretentive Drug Delivery Systems Market: Tablets Segment Dominated And Accounted For The Largest Revenue Share

 Gastroretentive Drug Delivery Systems Industry Overview

The global gastroretentive drug delivery systems market size was valued at USD 11.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.4% from 2021 to 2028. Pharmaceutical companies are taking initiative with changing requirements and are constantly investing in developing gastroretentive drug delivery systems (DDSs) is the factor estimated to augment market growth. The rising disease burden throughout the world and proven efficacy of gastroretentive drug delivery systems in addressing several gastric-related disorders such as gastric ulcer, and peptic ulcer are anticipated to accelerate the overall market progression.

The market for gastroretentive drug delivery systems experienced a mild impact of the ongoing COVID-19 pandemic in some regions due to production restrictions during mid-2020. However, the restraining effect was negated with growing demand, online prescriptions, and e-pharmacy services. The market in Japan was unimpacted during the first wave of COVID-19 owing to its well-established healthcare infrastructure.


Gather more insights about the market drivers, restraints and growth of the Global Gastroretentive Drug Delivery Systems market


Helicobacter pylori infection is among the most common human infection globally. According to the article published by the University of Arizona, H.pylori infection is higher in developing countries than the developed countries. The incidence of new infections in developing countries is 3 to 10% of the population compared to 0.5% in developed economies. H. Pylori infection is among the known cause of gastroduodenal ulcer disease, gastritis, and gastric cancer. The prevention and management of the disorder can be achieved by enhancing mucosal protection and decreasing the level of gastric acidity. Gastroretentive drug delivery systems extend the gastric retention time, thereby aggregating the concentration of the drug at the application site, possibly reducing essential dosage and improving its bioavailability. The increasing prevalence of H. pylori infection globally is anticipated to boost the growth of the market for gastroretentive drug delivery systems.

Gastroretentive Drug Delivery (GRDD) technology has emerged as an efficient approach for the controlled delivery of various therapeutic molecules which enhances bioavailability. In current years, technological and scientific advancements are made in research and development activities of rate-controlled oral drug delivery methods by overcoming physiological difficulties, including unpredictable gastric emptying times and short gastric residence times. GRDDS has potential application to advance the oral delivery of drugs, for which extended retention in the upper GI tract can enhance their oral bioavailability as well as their therapeutic outcome.

Currently, technological and scientific advancements are undertaken for rate-controlled oral drug delivery systems by disabling physiological difficulties, including unpredictable gastric emptying times as well as short gastric residence times. Thus, to overcome such difficulties, the gastroretentive drug delivery system is designed for longer gastric retention time and will prolong the time within which drug absorption can occur, thereby surging its preference among patients.


Browse through Grand View Research's Healthcare Industry Related Reports

  • Drug Delivery Devices Market - The global drug delivery devices market size was valued at USD 215.4 billion in 2019 and is anticipated to expand at a CAGR of 6.15% over the forecast period.
  • Subcutaneous Drug Delivery Devices Market - The global subcutaneous drug delivery devices market size was valued at USD 21.2 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 10.4% from 2020 to 2027.


Gastroretentive Drug Delivery Systems Industry Segmentation

Grand View Research has segmented the global gastroretentive drug delivery systems market on the basis of type, dosage form, distribution channel, and region:

Gastroretentive DDS Type Outlook (Revenue, USD Million, 2016 - 2028)

  • High Density Systems
  • Expandable Drug Delivery Systems
  • Bioadhesive Drug Delivery Systems
  • Floating Drug Delivery Systems
  • Others

Gastroretentive DDS Dosage Form Outlook (Revenue, USD Million, 2016 - 2028)

  • Tablets
  • Liquid
  • Microspheres
  • Capsule
  • Others

Gastroretentive DDS Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Gastroretentive Drug Delivery Systems Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA (Middle East & Africa)


Key Companies profiled:

Some prominent players in the global Gastroretentive Drug Delivery Systems Industry include

  • Hoffmann La Roche
  • Ranbaxy
  • GlaxoSmithKline
  • Pharmacia
  • Depomed
  • Alcon, Inc.
  • Lupin
  • Galanix
  • Sun Pharma


Order a free sample PDF of the Gastroretentive Drug Delivery Systems Market Intelligence Study, published by Grand View Research.


About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.


Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments

Post a Comment

Popular posts from this blog

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p...
Read more

All Countries Dialyzer Industry 2013-2028 - Market Size, Share, Outlook, Growth, Key Players and Forecast

The global Dialyzer market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Dialyzer from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dialyzer market. Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-dialyzer-market/request-sample Leading players of Dialyzer including: • Fresenius Medical Care • Baxter • Nipro • Asahi Kasei • Toray • B.Braun • Nikkiso • Medtronic • Kawasumi • Medica • Wego • Lengthen • Peony Medical • Chengdu OCI • Bain Medical Equipment Market split by Type, can be divided into: • Flat Type Dialyzer • Coil Tube Dialyzer • Ho...
Read more

Insights into the Medical Waste Disposal Category: A Comprehensive Procurement Intelligence Report

  Medical Waste Disposal Category Overview The medical waste disposal category is anticipated to grow at a CAGR of 6.0% from 2023 to 2030. Appropriate disposal of medical trash is the key challenge for healthcare providers across the globe. Rising awareness about the benefits of proper medical waste management for treatment, recycling, and disposal of medical trash has boosted the growth of the category. According to the World Health Organization Study Report 2022, countries with low income generate over 0.2 kg of medical trash per day per hospital bed, whereas countries with high income generate hazardous waste of up to 0.5 kg per hospital bed each day. Moreover, rising government initiatives and strict rules and regulations for waste management are also expected to drive the category. For instance, in December 2022, an MOU was signed between the Center for Health Environment Research and Development and Can Tho Central General Hospital under USAID’s Reducing Pollution Project. T...
Read more